Skip to Content

Join the 'Breast Cancer, Metastatic' group to help and get support from people like you.

Breast Cancer, Metastatic News

Related terms: Metastatic Breast Cancer

Mammogram Decision Hinges on Patient-Doc Talk, Ob-Gyn Group Says

Posted 1 day 6 hours ago by Drugs.com

THURSDAY, June 22, 2017 – As the debate continues about the best time for mammograms, the American College of Obstetricians and Gynecologists (ACOG) is asking women to add their voice to the discussion. In updated guidelines on breast cancer screening for average-risk women, ACOG emphasized shared decision-making between a woman and her doctor about when to start mammography screening and how often to do it. "What is critically important is that the patient's value and preferences are factored into that decision-making process," said Dr. Christopher Zahn, ACOG's vice president of practice activities. The new guidelines, Zahn said, are "empowering women to be involved in that decision." ACOG recommends that women at average risk of breast cancer be offered screening mammography beginning at age 40. The decision about whether to start at that age, however, should be made by a woman and ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative

Asian Women Less Likely to Get Follow-up After Abnormal Mammogram

Posted 11 days ago by Drugs.com

MONDAY, June 12, 2017 – Asian women in the San Francisco area were less likely than white women to get follow-up tests following an abnormal mammogram result, researchers report. Women who receive suspicious mammogram results are urged to get checked in a timely manner to rule out breast cancer, which should be treated as early as possible to ensure the best possible outcomes, the study authors said. However, the researchers, led by Kim Hanh Nguyen and Dr. Leah Karliner of the University of California, San Francisco, explained that many population-based breast cancer studies don't include Asians or differentiate among individual groups of patients. "Rather than being a monolithic group, Asians are, in fact, very diverse in nationalities, language, immigration history, education, and economic background. Recognizing differences among Asians may help clinicians develop better rapport and ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

Drug Helps Fight Breast Tumors Tied to 'Cancer Genes'

Posted 19 days ago by Drugs.com

SUNDAY, June 4, 2017 – A twice-daily pill could help some advanced breast cancer patients avoid or delay follow-up sessions of chemotherapy, a new clinical trial reports. The drug olaparib (Lynparza) reduced the chances of cancer progression by about 42 percent in women with breast cancer linked to BRCA1 and BRCA2 gene mutations, according to the study. Olaparib delayed cancer progression by about three months. The drug also caused tumors to shrink in three out of five patients who received the medication, the researchers reported. "Clearly the drug was more effective than traditional chemotherapy," said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society. "This is a group where a response is more difficult to obtain – a young group with a more aggressive form of cancer – and nonetheless we saw a close to 60 percent objective response rate," he said. The ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Lynparza, Olaparib

Drug Xeloda Prolongs Survival for Some Breast Cancer Patients

Posted 31 May 2017 by Drugs.com

WEDNESDAY, May 31, 2017 – A drug called Xeloda can extend the lives of some women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds. Oncologists said the results are "practice-changing." "This drug is already approved, and we've been using it for a long time in cancer treatment," said Dr. Stephen Malamud, an oncologist at Mount Sinai in New York City. Xeloda (capecitabine) is a pill, so it's easy to take and is "much less toxic" than standard chemotherapy, noted Malamud, who was not involved in the new research. "Most importantly," he said, "it extended overall survival in this study." In 1998, Xeloda was approved in the United States for advanced breast cancer that had spread to distant sites in the body. The new trial, done in Japan and South Korea, tested the drug for a different group of patients. It focused on 910 women whose breast tumors were ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Xeloda, Herceptin, Breast Cancer - Adjuvant, Capecitabine, Breast Cancer, Prevention, Breast Cancer - Palliative

Yoga, Meditation May Ease Some Breast Cancer Symptoms

Posted 19 May 2017 by Drugs.com

FRIDAY, May 19, 2017 – The diagnosis and treatment of breast cancer can come with a lot of anxiety, depression and other symptoms that affect quality of life. But mind-body therapies, such as yoga or meditation, may help ease these troubling concerns, a new study suggests. The researchers reviewed previous studies done on 80 integrative therapies. "We have good evidence that [some] mind-body therapies – such as meditation, yoga, relaxation – can provide benefit to breast cancer patients during and after treatment," said study researcher Heather Greenlee. She's an assistant professor of epidemiology at Columbia University's Mailman School of Public Health. "And we do have evidence that acupuncture is very useful in managing pain," she added. Evidence about dietary supplements and botanicals, however, are lacking when it comes to helping symptoms and side effects, she said. Greenlee ... Read more

Related support groups: Depression, Cancer, Major Depressive Disorder, Breast Cancer, Dysthymia, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

More U.S. Women Living Longer With Advanced Breast Cancer

Posted 18 May 2017 by Drugs.com

THURSDAY, May 18, 2017 – The number of U.S. women living with the most advanced stage of breast cancer has been rising since the 1990s, a new study finds. Researchers say that treatment advances, allowing more breast cancer patients to survive longer, are one likely reason. The general aging of the U.S. population is another. Right now, the study estimated, close to 155,000 U.S. women are living with metastatic breast cancer – cancer that has spread beyond the breast to distant sites in the body. That is up from roughly 105,000 in 1990. Breast cancer experts said the figures are actually the first estimates of how many U.S. women are living with metastatic disease. A number has been hard to come by, they said, because there is no national system that tracks cancer recurrences: Since U.S. women are typically diagnosed with earlier-stage breast cancer, most metastatic cases would – ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

More Cancers Caught Early Since Obamacare

Posted 18 May 2017 by Drugs.com

THURSDAY, May 18, 2017 – More cancers have been spotted in their early stages since the Affordable Care Act (ACA) became the law of the land, new research finds. Finding breast, colon, cervical and lung cancers early greatly improves the odds of successful treatment, said study author Xuesong Han. She's the strategic director of health policy and health care delivery research at the American Cancer Society. "We wanted to see if the introduction of the ACA affected the diagnosis of these cancers," she said. Although the increase in early-stage cancer diagnosis was only 1 percent, it's a significant increase that includes thousands of patients whose cancer might not have been found until it was too late for effective treatment and potential cure, Han noted. The increases in diagnosis of lung and cervical cancer were mostly among people on Medicaid, she said. A large part of the ACA is ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Cervical Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Could Tai Chi Ease Insomnia in Breast Cancer Survivors?

Posted 12 May 2017 by Drugs.com

FRIDAY, May 12, 2017 – For breast cancer survivors who struggle with sleep, a new study suggests that tai chi might calm their restless nights. Researchers found this slow-moving form of meditation was as good as talk therapy and more effective than medication in treating insomnia and reducing the risk for sleep loss-related health issues, including depression, fatigue and a weakened immune system. "Breast cancer survivors often don't just come to physicians with insomnia. They have insomnia, fatigue and depression," said study leader Dr. Michael Irwin. He directs UCLA's Cousins Center for Psychoneuroimmunology at the Semel Institute for Neuroscience and Human Behavior, in Los Angeles. "And this intervention, tai chi, impacted all those outcomes in a similar way, with benefits that were as robust as the gold standard treatment for insomnia [talk therapy]," Irwin added in a UCLA news ... Read more

Related support groups: Sleep Disorders, Insomnia, Fatigue, Breast Cancer, Drowsiness, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Hypersomnia, Breast Cancer, Prevention, Breast Cancer - Palliative

Hope for 1st Drug Against Lymphedema, a Cancer Complication

Posted 10 May 2017 by Drugs.com

WEDNESDAY, May 10, 2017 – Many cancer patients, especially those who've undergone breast cancer treatment, experience painful, swollen limbs, a condition called lymphedema. Now researchers say they've found an underlying mechanism that could eventually lead to the first drug therapy for the debilitating condition. The findings come from research in mice and human cells. However, there's already a clinical trial underway to see whether these lab discoveries will translate into a new lymphedema treatment. It's estimated that 10 million Americans have lymphedema, said Dr. Stanley Rockson, one of the senior researchers on the study. "Even though many people might not recognize the term, it's a very common condition," said Rockson, a professor at Stanford University School of Medicine in Stanford, Calif. People with lymphedema have excess fluid buildup in parts of the body, usually the arms ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ketoprofen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Orudis, Ketoprofen/lidocaine, Ketamine/ketoprofen/lidocaine, Actron, Orudis KT, Nexcede, Vopac, LidoProfen, Oruvail

More Asian-American Women Getting Breast Cancer

Posted 15 Apr 2017 by Drugs.com

FRIDAY, April 14, 2017 – Breast cancer rates among Asian-Americans are steadily rising in contrast to other racial/ethnic groups, a new study suggests. Researchers from the Cancer Prevention Institute of California reviewed data from 1988 to 2013 on breast cancer among women in California from seven Asian ethnic groups. These included Chinese, Japanese, Koreans, Filipinos, Vietnamese, South Asians (Asian Indians and Pakistanis), and Southeast Asians (Cambodians, Laotians, Hmong, Thai). During the study period, all of these groups – except Japanese women – had an overall increase in breast cancer incidence. The largest increases were among Koreans, South Asians and Southeast Asians, the study authors said. "These patterns warrant additional attention to public health prioritization to target disparities in access to care, as well as further research in identifying relevant breast ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention

Mammogram Guidelines Have Changed, But Are Doctors Listening?

Posted 10 Apr 2017 by Drugs.com

MONDAY, April 10, 2017 – Four of five doctors still recommend annual mammograms for women in their early 40s, despite guideline changes that have pushed back the age for yearly breast cancer screening, a new survey shows. Overall, 81 percent of physicians surveyed said they suggest annual mammograms for women aged 40 to 44, while more than two-thirds recommend regular mammograms for women aged 75 or older. "Gynecologists were, in general, more likely to recommend routine mammograms," added lead researcher Dr. Archana Radhakrishnan, an internist with Johns Hopkins University in Baltimore. These practices run counter to guidelines issued by the American Cancer Society, which recommends annual screening starting at 45 and screening every other year from age 55 onward, researchers said in background notes. The doctors also are ignoring the advice of the U.S. Preventive Services Task Force ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Body Imaging

Ibrance (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer

Posted 3 Apr 2017 by Drugs.com

March 31, 2017 – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for its first-in-class cyclin dependent kinase 4/6 (CDK 4/6) inhibitor, Ibrance (palbociclib), based on the results from the confirmatory Phase 3 trial PALOMA-2. The FDA action converts the accelerated approval of Ibrance to regular approval and broadens the range of anti-hormonal therapy that may be administered with Ibrance. Ibrance now is indicated in combination with an aromatase inhibitor, expanding on its earlier indication in combination with letrozole, as initial endocrine based therapy in postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Ibrance is the first CDK 4/6 inhibitor approved by the FDA. Ibrance was ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ibrance, Palbociclib

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Breast Cancer - Adjuvant, Melanoma - Metastatic

Preventive Mastectomy Rates Vary by State

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – In certain areas of the United States, more women diagnosed with early stage breast cancer are choosing to have the unaffected breast removed, new research finds. The study also found that younger women are especially likely to have the second breast removed. Nearly half of women under age 45 diagnosed with early breast cancer in five states opted for the procedure, said the study's senior author, Dr. Ahmedin Jemal. He's vice president of the American Cancer Society's Surveillance and Health Services Research Program. The five states are Colorado, Iowa, Missouri, Nebraska and South Dakota. The study included records from 1.2 million women from 45 states and Washington, D.C. All patients were 20 and older. All had been diagnosed with early stage breast cancer in one breast and were treated with surgery between 2004 and 2012. Between those years, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Vascular Surgery

Smokers May Be Prone to Risks From Breast Cancer Radiation Therapy

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – Breast cancer patients who smoke have an increased risk for serious long-term complications from radiation therapy, a new study finds. "This research highlights that breast cancer patients who smoke need to be offered help and support in order to try and quit to minimize any risks from their treatment," Dr. Julie Sharp said in a Cancer Research UK news release. She's head of health information for the research and awareness charity based in the United Kingdom. "It's important to remember that modern-day radiotherapy techniques have been refined and improved to make sure it is targeted and effective while reducing the risk of side effects," Sharp added. British researchers looked at data from nearly 41,000 breast cancer patients. The information came from 75 different studies on radiation therapy for breast cancer. The researchers found that the long-term ... Read more

Related support groups: Smoking, Breast Cancer, Smoking Cessation, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Palliative, History - Radiation Therapy

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

tamoxifen, Arimidex, Femara, anastrozole, letrozole, Xeloda, Herceptin, Taxol, Taxotere, view more... Faslodex, capecitabine, Ibrance, Gemzar, paclitaxel, gemcitabine, eribulin, docetaxel, Abraxane, Tykerb, bevacizumab, Fareston, Perjeta, fulvestrant, Kadcyla, Nolvadex, lapatinib, trastuzumab, Tamoxifen Hexal, Ixempra, pertuzumab, Tamoxen, Tamosin, Halaven, Kisqali, Docefrez, Genox, Soltamox, toremifene, ribociclib, palbociclib, ado-trastuzumab emtansine, paclitaxel protein-bound, Onxol, Tamofen, Emblon, Tamone, ixabepilone, Nolvadex D